Laborate Pharmaceuticals India

What Laborate Pharmaceuticals India does

Laborate Pharmaceuticals India Limited is an Indian generic pharmaceutical manufacturer founded in 1985 by first-generation entrepreneurs Ajay Bhatia and Sanjay Bhatia, with second-generation Directors Parag Bhatia and Arpit Bhatia now driving international expansion. The company operates five manufacturing plants — one in Panipat (Haryana), three in Paonta Sahib (Himachal Pradesh, a tax-free industrial zone), and one in Salwan, Karnal — producing oral solids, small-volume parenterals, ophthalmic, topical, oral liquid, dry syrup, and ayurvedic/cosmetic dosage forms at scale (approximately 18.5 million tablets, 15.5 million capsules, and 1.35 million injection ampoules per day). Product lines are organized under brands including Elite, GPP Axalade, Aqualab, Labolia Beaute (cosmetics), and ROW (Rest of World), covering more than 1500 formulations across antibiotics, analgesics, cardiovascular, antidiabetics, nutritional supplements, and consumer healthcare categories.

The company generates revenue primarily through B2B sales of branded generics, OTC products, and nutraceuticals via distribution networks covering all 29 Indian states and 51 countries across Africa, the Americas, and Asia. Go-to-market is event-driven for international expansion (CPHI Spain, Arab Health Dubai) and distribution-led domestically. Laborate holds WHO-GMP, EU-GMP (obtained 2025), and US-FDA-aligned manufacturing certifications, plus regulatory approvals from over 35 country-level agencies (NAFDAC, PPB, NDA, FDA Ghana, SBDMA, MOH approvals), with a pipeline of 20 dossiers targeted at Europe, UK, Australia, and South Africa. The company is privately held by the Bhatia family, with no disclosed institutional or external ownership.

Name

Laborate Pharmaceuticals India

Legal name

Laborate Pharmaceuticals India Limited

Website

https://laborate.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Laborate Pharmaceuticals India is a privately-held Indian generic drug manufacturer founded in 1985, operating five plants that produce 1500+ formulations across oral, injectable, ophthalmic, topical, and ayurvedic dosage forms for 29 Indian states and 51 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

Oral Solid Dose (OSD) Generics (HLAIABAD)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Dosage formulations
• Pharmaceutical exports
• Contract manufacturing

Headquarters

HQ city

Panipat

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and selling pharmaceutical products including generic drugs, branded generics, over-the-counter (OTC) products, and nutraceuticals across domestic and international markets. Revenue generated through sale of formulations manufactured at five production facilities.
2. Contract Manufacturing: The company is exploring contract manufacturing arrangements and co-development partnerships with clients in Europe and UK, leveraging EU-GMP certified facilities for finished formulations supply.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Laborate Pharmaceuticals India manufactures and sells generic drugs, branded generics, over-the-counter (OTC) products, nutraceuticals, Ayurvedic medicines, and personal care/cosmetic formulations across multiple dosage forms (tablets, capsules, injections, ophthalmic, topical, oral liquids). The company operates five WHO-GMP and USFDA-compliant manufacturing facilities producing 1,500+ formulations supplied to healthcare providers, pharmacies, and distributors across 29 Indian states and 51+ international markets.

Product overview

Laborate Pharmaceuticals India is a pharmaceutical manufacturer offering an extensive portfolio of over 1000 products spanning generic pharma, ayurvedic, and personal care categories. The company operates five manufacturing facilities producing a full range of dosage forms including oral solids (tablets, capsules), injectable preparations (ampules, vials, dry powder), ophthalmic preparations, topical applications (creams, ointments, gels, lotions), oral liquids, and dry syrups. The product portfolio is organized under distinct brand lines: Elite (comprehensive pharmaceutical formulations), GPP Axalade (120+ products including pediatric range), Aqualab (formulations and consumer products), Labolia Beaute (personal care/cosmetics), and ROW (Rest of World formulations for international markets). The company serves both domestic markets across 29 Indian states and exports to 51+ countries globally.

Differentiator

Problem solved

Functional benefit

Brands

• Ascoff: Cough syrup brand mentioned in news article about codeine-based cough syrup investigations.
• Labolia Beaute

Products and services

• Elite Comprehensive pharmaceutical brand offering a wide range of generic medications including tablets, capsules, injections, eye/ear drops, topical preparations, dry syrups, and tonics across multiple therapeutic categories. Targeted at domestic and international healthcare providers, pharmacies, and distributors.
• GPP Axalade Pharmaceutical brand featuring over 120 products including tablets, capsules, injectable preparations, pediatric range, liquid formulations, and external preparations. Targeted at distributors, pharmacies, and prescribers across therapeutic categories.
• Aqualab Pharmaceutical brand offering formulations across tablets, capsules, syrups, creams, injections, and consumer products including personal care items, health supplements, and diagnostic devices. Targeted at healthcare providers, pharmacies, and consumer health channels.
• Labolia Beaute Personal care and cosmetic product line featuring face washes, body lotions, charcoal face wash, and beauty products. Targeted at end consumers through dedicated brand website and beauty retail channels.
• ROW (Rest of World) Formulations International market formulations including WHO-GMP certified products for regulated export markets across Africa, Asia, and other regions. Targeted at international pharmaceutical distributors, importers, and government health agencies in 51+ countries.
• Contract Manufacturing and Co-development Services Contract manufacturing and co-development services leveraging EU-GMP certified facilities to supply finished formulations to pharmaceutical clients in Europe and UK. Targeted at European pharmaceutical companies seeking GMP-compliant supply partners.

Quantifiable outcome

• 40 years of successful pharmaceutical product development and marketing
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators20 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Cipla: One of India's largest generic manufacturers with strong global export footprint across 80+ countries, finished dosage forms (OSD, injectables, ophthalmic, respiratory) and a growing OTC/consumer health vertical. Highly comparable in product mix and geographic distribution strategy.
• Mankind Pharma: Large Indian pharma with strong domestic OTC and branded generics franchise across 30+ therapeutic categories, scaling export operations. Direct comparable on multi-dosage manufacturing and India-first go-to-market with international expansion.
• Glenmark Pharmaceuticals: India-headquartered generics and specialty company with global manufacturing, finished dosage exports, and growing OTC business. Similar multi-dosage, multi-region operating model.
• Torrent Pharmaceuticals: Mid-to-large Indian generic manufacturer with strong domestic branded presence and growing international business in regulated markets. Overlap on dosage forms (OSD, injectables) and emerging/regulated export strategy.
• Lupin: Major Indian generic manufacturer particularly strong in oral solid dosage, cephalosporins, and APIs, with deep regulated-market presence and significant USFDA-approved capacity. Comparable in beta-lactam/cephalosporin segmentation and OSD focus.
• Alkem Laboratories: Indian mid-tier generics player with manufacturing facilities in India and the US, strong domestic formulations franchise, and growing international exports. Comparable scale and dosage-form portfolio.

Broad incumbents

• Sun Pharmaceutical Industries: Largest pharma company in India with global generics, finished dosage manufacturing across OSD/injectables/ophthalmic, and a sizable API business. Direct overlap on dosage forms and export markets; broader scale and specialty/biosimilar presence.
• Dr. Reddy's Laboratories: Integrated Indian generic major with global finished dosage exports (USFDA-approved facilities), strong OSD and injectable capabilities, plus proprietary/OTC businesses. Overlaps with Laborate on regulated-market strategy and dosage forms.
• Aurobindo Pharma: Indian generics heavyweight with extensive USFDA/EU-GMP approved facilities producing OSD, injectables, and ARVs at scale. Operates a similar contract manufacturing / dossier-filing playbook across regulated and emerging markets.
• Zydus Lifesciences (Cadila): Indian integrated pharma with substantial finished dosage and API manufacturing, USFDA-approved plants, and an OTC/consumer wellness portfolio (Zydus Wellness). Comparable in API+formulation integration and regulated-market dossier strategy.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/laborate.pvt.ltd
• LinkedInlinkedin.com/company/laborate-pharmaceuticals-india-limited

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laborate Pharmaceuticals India